Bloodstream infection after living donor liver transplantation

被引:41
作者
Hashimoto, Masao [1 ]
Sugawara, Yasuhiko [1 ]
Tamura, Sumihito [1 ]
Kaneko, Junichi [1 ]
Matsui, Yuichi [1 ]
Togashi, Junichi [1 ]
Makuuchi, Masatoshi [1 ]
机构
[1] Univ Tokyo, Grad Sch Med, Dept Surg, Artificial Organ & Transplantat Div,Bunkyo Ku, Tokyo 1138655, Japan
关键词
D O I
10.1080/00365540701824116
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
There are no detailed studies on the prevalence or clinical magnitude of bloodstream infection (BSI) following living donor liver transplantation (LDLT). The study aimed to assess the incidence and analyze the risk factors for BSI after LDLT. Univariate and multivariate analyses were performed to identify the independent risk factors for postoperative BSI. Postoperatively, 26 episodes of BSI occurred in 21 of 242 studied adult patients by median postoperative d 35. Five patients had primary BSI. The source was unknown in 3 patients and an intravascular catheter in 2. The other 16 patients had secondary BSI. Secondary BSI was caused by surgical site infection in 8 patients, followed by intra-abdominal infection in 5, pneumonia in 2, and both surgical site infection and intra-abdominal infection in 1. The most frequent pathogen isolated was MRSA, which was detected in 4 patients. Surveillance culture detected the same isolates prior to BSI in 14 of 26 (50%) episodes. Diabetes mellitus and serum albumin level less than 2.4 g/dl independently predicted postoperative BSI. Perioperatively, screening for and taking actions against pathogen including MRSA should be performed in LDLT patients.
引用
收藏
页码:509 / 516
页数:8
相关论文
共 30 条
  • [1] Akamatsu N, 2005, HEPATO-GASTROENTEROL, V52, P197
  • [2] ASPEN Board of Directors and the Clinical Guidelines Task Force, 2002, JPEN J Parenter Enteral Nutr, V26, p1SA
  • [3] Antifungal prophylaxis in liver transplant patients: A systematic review and meta-analysis
    Cruciani, Mario
    Mengoli, Carlo
    Malena, Marina
    Bosco, Oliviero
    Serpelloni, Giovanni
    Grossi, Paolo
    [J]. LIVER TRANSPLANTATION, 2006, 12 (05) : 850 - 858
  • [4] Delamaire M, 1997, DIABETIC MED, V14, P29, DOI 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO
  • [5] 2-V
  • [6] Demetris AJ, 1997, HEPATOLOGY, V25, P658
  • [7] CDC DEFINITIONS FOR NOSOCOMIAL INFECTIONS, 1988
    GARNER, JS
    JARVIS, WR
    EMORI, TG
    HORAN, TC
    HUGHES, JM
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 1988, 16 (03) : 128 - 140
  • [8] Gavin JR, 1997, DIABETES CARE, V20, P1183
  • [9] HORAN TC, 1992, INFECT CONT HOSP EP, V13, P606
  • [10] Surgical site infection in living-donor liver transplant recipients: A prospective study
    Iinuma, Y
    Senda, K
    Fujihara, N
    Saito, T
    Takakura, S
    Kudo, T
    Kiuchi, T
    Tanaka, K
    Ichiyama, S
    [J]. TRANSPLANTATION, 2004, 78 (05) : 704 - 709